These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 21181026

  • 1. [Evaluation years in leprosy patients treated with single dose alternative scheme ROM (rifampin, ofloxacin, minocycline), after seven to nine].
    Diniz LM, Catabriga MD, Souza Filho JB.
    Rev Soc Bras Med Trop; 2010; 43(6):695-9. PubMed ID: 21181026
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
    Majumder V, Saha B, Hajra SK, Biswas SK, Saha K.
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091
    [Abstract] [Full Text] [Related]

  • 3. Is there a role for rifampicin, ofloxacin and minocycline (ROM) therapy in the treatment of leprosy? Systematic review and meta-analysis.
    Setia MS, Shinde SS, Jerajani HR, Boivin JF.
    Trop Med Int Health; 2011 Dec; 16(12):1541-51. PubMed ID: 21914093
    [Abstract] [Full Text] [Related]

  • 4. Parallel assessment of 24 monthly doses of rifampin, ofloxacin, and minocycline versus two years of World Health Organization multi-drug therapy for multi-bacillary leprosy.
    Villahermosa LG, Fajardo TT, Abalos RM, Cellona RV, Balagon MV, Dela Cruz EC, Tan EV, Walsh GP, Walsh DS.
    Am J Trop Med Hyg; 2004 Feb; 70(2):197-200. PubMed ID: 14993633
    [Abstract] [Full Text] [Related]

  • 5. Single-dose ROM treatment for multilesion paucibacillary leprosy--further observations.
    Revankar CR, Bulchand HO, Pai VV, Ganapati R.
    Int J Lepr Other Mycobact Dis; 2002 Mar; 70(1):37-8. PubMed ID: 12120040
    [No Abstract] [Full Text] [Related]

  • 6. Field trials of a single dose of the combination rifampicin-ofloxacin-minocycline (ROM) for the treatment of paucibacillary leprosy.
    Gupte MD.
    Lepr Rev; 2000 Dec; 71 Suppl():S77-80. PubMed ID: 11201893
    [No Abstract] [Full Text] [Related]

  • 7. A comparative evaluation of skin and nerve histopathology in single skin lesion leprosy.
    Reddy RR, Singh G, Sacchidanand S, Okade R, Shivakumar V, Uday A, Haneef NS.
    Indian J Dermatol Venereol Leprol; 2005 Dec; 71(6):401-5. PubMed ID: 16394481
    [Abstract] [Full Text] [Related]

  • 8. A randomized controlled trial to compare cure and relapse rate of paucibacillary multidrug therapy with monthly rifampicin, ofloxacin, and minocycline among paucibacillary leprosy patients in Agra District, India.
    Kumar A, Girdhar A, Girdhar BK.
    Indian J Dermatol Venereol Leprol; 2015 Dec; 81(4):356-62. PubMed ID: 26144850
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of single-dose chemotherapy (rifampicin, ofloxacin and minocycline-ROM) in PB leprosy patients with 2 to 5 skin lesions, India: randomised double-blind trial.
    Manickam P, Nagaraju B, Selvaraj V, Balasubramanyam S, Mahalingam VN, Mehendale SM, Pannikar VK, Gupte MD, Team of Study Investigators.
    Indian J Lepr; 2012 Dec; 84(3):195-207. PubMed ID: 23484334
    [Abstract] [Full Text] [Related]

  • 10. Single-dose rifampicin, oflaxicin and minocycline (ROM) therapy for single leprosy lesions.
    Ramu G.
    Lepr Rev; 1998 Mar; 69(1):78-82. PubMed ID: 9628098
    [No Abstract] [Full Text] [Related]

  • 11. Single dose multidrug therapy for single lesion paucibacillary leprosy.
    Kars HK.
    Indian J Lepr; 1998 Mar; 70(2):214-5; author reply 219-21. PubMed ID: 9724859
    [No Abstract] [Full Text] [Related]

  • 12. Single dose multidrug therapy for single lesion paucibacillary leprosy.
    Prasad KN.
    Indian J Lepr; 1998 Mar; 70(2):215-6; author reply 219-21. PubMed ID: 9724860
    [No Abstract] [Full Text] [Related]

  • 13. A comparative trial of single dose chemotherapy in paucibacillary leprosy patients with two to three skin lesions.
    2-3 Lesion Multicentre Trial Group.
    Indian J Lepr; 2001 Mar; 73(2):131-43. PubMed ID: 11579649
    [Abstract] [Full Text] [Related]

  • 14. A comparative clinico-pathological study of single dose ROM in paucibacillary leprosy patients with 1-3 skin lesions.
    Deshmukh AR, Dhurat RS, Jerajani HR.
    Indian J Lepr; 2003 Mar; 75(3):209-17. PubMed ID: 15267190
    [Abstract] [Full Text] [Related]

  • 15. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
    Mane I, Cartel JL, Grosset JH.
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
    [Abstract] [Full Text] [Related]

  • 16. Single dose multidrug therapy for single lesion paucibacillary leprosy.
    Porichha D.
    Indian J Lepr; 1998 Jun; 70(2):213-4; author reply 219-21. PubMed ID: 9724858
    [No Abstract] [Full Text] [Related]

  • 17. Single dose 'ROM' therapy--is it really effective?
    Mandal AK.
    Natl Med J India; 1998 Jun; 11(5):247. PubMed ID: 10997176
    [No Abstract] [Full Text] [Related]

  • 18. Single dose multidrug therapy for single lesion paucibacillry leprosy.
    Salafia A.
    Indian J Lepr; 1998 Jun; 70(2):216-9; author reply 219-21. PubMed ID: 9724861
    [No Abstract] [Full Text] [Related]

  • 19. Single lesion paucibacillary leprosy: baseline profile of the Brazilian Multicenter Cohort Study.
    Martelli CM, Stefani MM, Gomes MK, Rebello PF, Peninni S, Narahashi K, Maroclo AL, Costa MB, Silva SA, Sacchetim SC, Nery JA, Salles AM, Gillis TP, Krahenbuhl JL, Andrade AL.
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):247-57. PubMed ID: 11221086
    [Abstract] [Full Text] [Related]

  • 20. Developing new MDT regimens for MB patients; time to test ROM 12 month regimens globally.
    Lockwood DN, Cunha Mda G.
    Lepr Rev; 2012 Sep; 83(3):241-4. PubMed ID: 23356024
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.